Pharma · Private company

Sumitomo Pharma America, Inc.

Track this companyFree. Adds Sumitomo Pharma America, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials2516 recruiting or active

Pipeline programs31From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline31

Leuprolide AcetatePhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
RelugolixPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
SEP-4199 CRPhase 3 · Depressive Episodes, Bipolar I DepressionClinicalTrials.gov · fetched Nov 12, 2026
Azacitidine (AZA)Phase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
azolesPhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
DSP-1083 implantationPhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
DSP-3077 Retinal Sheet Cohort 1Phase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
DSP-3077 Retinal Sheet Cohort 2Phase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
DSP-3077 Retinal Sheet Cohort 3Phase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
EnzomenibPhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
GilteritinibPhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
Intensive chemotherapy with 7 + 3Phase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
MomelotinibPhase 2 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
NusivertibPhase 2 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
RuxolitinibPhase 2 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
Sham surgery treatmentPhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
SMP3124LPPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
VenetoclaxPhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
[14C]-DSP-5336Phase 1 · Advanced Hematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
AbirateronePhase 1 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
ApalutamidePhase 1 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
DocetaxelPhase 1 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
DSP-0390Phase 1 · High Grade GliomaClinicalTrials.gov · fetched Nov 12, 2026
DSP-5336Phase 1 · Advanced Hematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
MethylprednisolonePhase 1 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
PrednisonePhase 1 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
RelugolixPhase 1 · Metastatic Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
TP-1454 monotherapyPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
TP-3654Phase 1 · MyelofibrosesClinicalTrials.gov · fetched Nov 12, 2026
BES-100Social Anxiety Disorder (SAD)ClinicalTrials.gov · fetched Nov 12, 2026
BVR-100Social Anxiety Disorder (SAD)ClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

DSP-0390 in Combination With Atezolizumab for Small Cell Lung CancerPHASE1 · RECRUITING · started Aug 3, 2026ClinicalTrials.gov NCT07545954 · fetched Nov 12, 2026
A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis PigmentosaPHASE1_PHASE2 · RECRUITING · started Apr 16, 2026ClinicalTrials.gov NCT06891885 · fetched Nov 12, 2026
How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood CancersPHASE1 · COMPLETED · started Mar 26, 2026ClinicalTrials.gov NCT07444268 · fetched Nov 12, 2026
Window of Opportunity Study of DSP-0390 in GliomasEARLY_PHASE1 · RECRUITING · started Apr 3, 2025ClinicalTrials.gov NCT06636162 · fetched Nov 12, 2026
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac TrialPHASE3 · RECRUITING · started Jan 31, 2025ClinicalTrials.gov NCT06650579 · fetched Nov 12, 2026
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's DiseasePHASE1_PHASE2 · RECRUITING · started Dec 18, 2024ClinicalTrials.gov NCT06753331 · fetched Nov 12, 2026
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 13, 2024ClinicalTrials.gov NCT06463457 · fetched Nov 12, 2026
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)ACTIVE_NOT_RECRUITING · started Oct 3, 2024ClinicalTrials.gov NCT06517940 · fetched Nov 12, 2026
SMP-3124LP in Adults With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Aug 14, 2024ClinicalTrials.gov NCT06526819 · fetched Nov 12, 2026
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate CancerPHASE2 · RECRUITING · started Aug 12, 2024ClinicalTrials.gov NCT06330805 · fetched Nov 12, 2026
Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)PHASE1 · RECRUITING · started Jun 1, 2024ClinicalTrials.gov NCT06482268 · fetched Nov 12, 2026
TP-3654 Food Effect StudyPHASE1 · COMPLETED · started Mar 4, 2024ClinicalTrials.gov NCT07492355 · fetched Nov 12, 2026
RecoverPC: Relugolix vs GnRH Agonist in Quality of LifePHASE2 · RECRUITING · started Feb 12, 2024ClinicalTrials.gov NCT05765500 · fetched Nov 12, 2026
ASCVD Management Using CCTA in Prostate Cancer Patients on ADTNA · RECRUITING · started Dec 15, 2023ClinicalTrials.gov NCT05879913 · fetched Nov 12, 2026
A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.NA · COMPLETED · started Sep 8, 2023ClinicalTrials.gov NCT06037668 · fetched Nov 12, 2026
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide AcetatePHASE3 · COMPLETED · started Jan 28, 2023ClinicalTrials.gov NCT05605964 · fetched Nov 12, 2026
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CICPHASE2_PHASE3 · RECRUITING · started Oct 12, 2022ClinicalTrials.gov NCT05491525 · fetched Nov 12, 2026
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYXCOMPLETED · started Oct 4, 2022ClinicalTrials.gov NCT05467176 · fetched Nov 12, 2026
A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).PHASE3 · TERMINATED · started Mar 17, 2022ClinicalTrials.gov NCT05227209 · fetched Nov 12, 2026
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)PHASE1_PHASE2 · RECRUITING · started Feb 28, 2022ClinicalTrials.gov NCT04988555 · fetched Nov 12, 2026
Study of DSP-0390 in Patients With Recurrent High-Grade GliomaEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Sep 8, 2021ClinicalTrials.gov NCT05023551 · fetched Nov 12, 2026
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerPHASE1 · COMPLETED · started Feb 18, 2021ClinicalTrials.gov NCT04666129 · fetched Nov 12, 2026
Phase 1 Study of Oral TP-1454PHASE1 · COMPLETED · started Jul 8, 2020ClinicalTrials.gov NCT04328740 · fetched Nov 12, 2026
A Study of Oral Nuvisertib (TP-3654) in Patients With MyelofibrosisPHASE1_PHASE2 · RECRUITING · started Dec 16, 2019ClinicalTrials.gov NCT04176198 · fetched Nov 12, 2026
High Dose Lurasidone for Patients With Treatment Resistant SchizophreniaPHASE4 · COMPLETED · started Oct 1, 2011ClinicalTrials.gov NCT01569659 · fetched Nov 12, 2026